How the return to routine creates a distinct opportunity for evidence-based nutraceutical formulations aligned with Q1 portfolio and innovation planning.
January 13, 2026
How the return to routine creates a distinct opportunity for evidence-based nutraceutical formulations aligned with Q1 portfolio and innovation planning.